NCT04088929View on ClinicalTrials.gov

The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

November 22, 2019

Study Completion Date

December 1, 2019

Conditions
Diabetic Neuropathies
Interventions
DRUG

CBD

A water-soluble sublingual tablet containing 20 mg of cannabidiol (CBD) and 0.1 mg of a proprietary blend of terpenes.

Trial Locations (1)

48310

Dr. Nakadar's Office, Sterling Heights

All Listed Sponsors
lead

Pure Green

INDUSTRY

NCT04088929 - The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter